A detailed history of Osprey Private Wealth LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Osprey Private Wealth LLC holds 50,310 shares of ABBV stock, worth $11.8 Million. This represents 4.23% of its overall portfolio holdings.

Number of Shares
50,310
Previous 39,110 28.64%
Holding current value
$11.8 Million
Previous $7.4 Billion 57.36%
% of portfolio
4.23%
Previous 4.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 08, 2025

BUY
$184.85 - $231.54 $2.07 Million - $2.59 Million
11,200 Added 28.64%
50,310 $11.6 Billion
Q2 2025

Jul 07, 2025

BUY
$170.16 - $206.27 $151,442 - $183,580
890 Added 2.33%
39,110 $7.4 Billion
Q1 2025

Apr 16, 2025

BUY
$169.2 - $216.66 $1.11 Million - $1.42 Million
6,575 Added 20.78%
38,220 $8.01 Billion
Q4 2024

Jan 27, 2025

BUY
$164.99 - $203.87 $30,523 - $37,715
185 Added 0.59%
31,645 $5.62 Billion
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $5.15 Million - $6.27 Million
31,460 New
31,460 $6.21 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Osprey Private Wealth LLC Portfolio

Follow Osprey Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osprey Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Osprey Private Wealth LLC with notifications on news.